| Primary |
| Drug Use For Unknown Indication |
33.6% |
| Thrombosis Prophylaxis |
9.9% |
| Angioplasty |
9.2% |
| Hypertension |
6.9% |
| Myocardial Infarction |
6.9% |
| Diabetes Mellitus |
4.6% |
| Product Used For Unknown Indication |
3.8% |
| Stent Placement |
3.8% |
| Acute Myocardial Infarction |
2.3% |
| Arthralgia |
2.3% |
| Coronary Artery Disease |
2.3% |
| Ischaemic Cardiomyopathy |
2.3% |
| Transient Ischaemic Attack |
2.3% |
| Anticoagulant Therapy |
1.5% |
| Asthma |
1.5% |
| Atrial Fibrillation |
1.5% |
| Carotid Artery Stenosis |
1.5% |
| Cerebrovascular Accident Prophylaxis |
1.5% |
| Glaucoma |
1.5% |
| Agranulocytosis |
0.8% |
|
| Bone Marrow Failure |
9.7% |
| Melaena |
8.1% |
| Thrombotic Thrombocytopenic Purpura |
8.1% |
| Death |
6.5% |
| Thrombocytopenia |
6.5% |
| Weight Decreased |
6.5% |
| Diarrhoea |
4.8% |
| Drug Interaction |
4.8% |
| Rash |
4.8% |
| Syncope |
4.8% |
| Thrombocytopenic Purpura |
4.8% |
| Urticaria |
4.8% |
| Dysarthria |
3.2% |
| Hepatitis Cholestatic |
3.2% |
| Malaise |
3.2% |
| Neutropenia |
3.2% |
| Pyrexia |
3.2% |
| Renal Failure |
3.2% |
| Respiratory Failure |
3.2% |
| Sepsis |
3.2% |
|
| Secondary |
| Thrombosis Prophylaxis |
18.2% |
| Stent Placement |
14.9% |
| Hypertension |
6.6% |
| Product Used For Unknown Indication |
6.6% |
| Atrial Fibrillation |
5.8% |
| Drug Use For Unknown Indication |
5.8% |
| Coronary Arterial Stent Insertion |
5.0% |
| Myocardial Infarction |
5.0% |
| Septic Shock |
5.0% |
| Catheterisation Cardiac |
4.1% |
| Carotid Artery Stenosis |
3.3% |
| Glaucoma |
3.3% |
| Breast Cancer |
2.5% |
| Diabetes Mellitus |
2.5% |
| Hypertensive Heart Disease |
2.5% |
| Myocardial Ischaemia |
2.5% |
| Acute Myocardial Infarction |
1.7% |
| Arteriosclerosis Coronary Artery |
1.7% |
| Benign Prostatic Hyperplasia |
1.7% |
| Herpes Zoster |
1.7% |
|
| Thrombocytopenia |
11.9% |
| Vasodilatation |
9.5% |
| Weight Decreased |
9.5% |
| Drug Intolerance |
7.1% |
| Rectal Haemorrhage |
7.1% |
| Drug Hypersensitivity |
4.8% |
| Duodenal Ulcer |
4.8% |
| Febrile Neutropenia |
4.8% |
| Haematemesis |
4.8% |
| Jaundice Cholestatic |
4.8% |
| Joint Injury |
4.8% |
| Subarachnoid Haemorrhage |
4.8% |
| Thrombotic Thrombocytopenic Purpura |
4.8% |
| Acute Myocardial Infarction |
2.4% |
| Angina Pectoris |
2.4% |
| Crohn's Disease |
2.4% |
| Dermatitis Exfoliative |
2.4% |
| Duodenal Ulcer Haemorrhage |
2.4% |
| Dyspnoea |
2.4% |
| Faeces Discoloured |
2.4% |
|
| Concomitant |
| Drug Use For Unknown Indication |
16.9% |
| Product Used For Unknown Indication |
16.5% |
| Hypertension |
15.1% |
| Rheumatoid Arthritis |
7.2% |
| Prophylaxis |
6.0% |
| Diabetes Mellitus |
4.7% |
| Anticoagulant Therapy |
4.1% |
| Cardiac Disorder |
3.6% |
| Pain |
3.6% |
| Blood Cholesterol Increased |
3.0% |
| Bronchopneumonia |
2.5% |
| Atrial Fibrillation |
2.3% |
| Immunodeficiency Common Variable |
2.2% |
| Osteoporosis |
2.2% |
| Hepatitis C |
2.0% |
| Non-small Cell Lung Cancer |
1.7% |
| Prophylaxis Against Gastrointestinal Ulcer |
1.7% |
| Arthritis |
1.6% |
| Depression |
1.6% |
| Gastric Disorder |
1.6% |
|
| Vomiting |
15.6% |
| Pyrexia |
7.4% |
| Weight Decreased |
7.4% |
| Syncope |
6.6% |
| Renal Failure |
5.7% |
| Pain |
4.9% |
| Transient Ischaemic Attack |
4.9% |
| Clostridium Colitis |
4.1% |
| Drug Ineffective |
4.1% |
| Hyperkalaemia |
4.1% |
| Myocardial Infarction |
4.1% |
| Psychomotor Hyperactivity |
4.1% |
| Weight Increased |
4.1% |
| Oedema Peripheral |
3.3% |
| Rash |
3.3% |
| Tachycardia |
3.3% |
| Toxic Epidermal Necrolysis |
3.3% |
| Urticaria |
3.3% |
| Vein Disorder |
3.3% |
| Ventricular Fibrillation |
3.3% |
|
| Interacting |
| Acute Coronary Syndrome |
20.0% |
| Anticoagulant Therapy |
20.0% |
| Mental Disorder |
20.0% |
| Panic Reaction |
20.0% |
| Sedative Therapy |
20.0% |
|
| Drug Interaction |
33.3% |
| Nephrolithiasis |
33.3% |
| Pulmonary Haemorrhage |
33.3% |
|
